Exacerbation of signs and symptoms of myasthenia gravis as well as new onset of symptoms of myasthenic disorder has been stated in individuals getting clarithromycin treatment.

BIAXIN as well as ranitidine bismuth citrate combo treatment is not suggested in patients with creatinine clearance much less compared to 25 mL/min (see INDICATIONS AND USAGE as well as CLINICAL STUDIES areas).

Your healthcare expert could also have the ability to tell you regarding ways to reduce or protect against some of these side impacts.

As compared to previous experience with clarithromycin monotherapy, the two-drug routine of clarithromycin and ethambutol was well endured and extended the moment to microbiologic relapse, greatly with reducing the introduction of clarithromycin resistant strains.

In community-acquired pneumonia research studies, 4 % of individuals ceased clarithromycin (the energetic substance consisted of in Biaxin) because of negative side effects.